BLTE
Price
$64.96
Change
+$1.93 (+3.06%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.07B
77 days until earnings call
IBIO
Price
$0.81
Change
-$0.01 (-1.22%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
16.07M
Interact to see
Advertisement

BLTE vs IBIO

Header iconBLTE vs IBIO Comparison
Open Charts BLTE vs IBIOBanner chart's image
Belite Bio
Price$64.96
Change+$1.93 (+3.06%)
Volume$1.35K
Capitalization2.07B
iBio
Price$0.81
Change-$0.01 (-1.22%)
Volume$733
Capitalization16.07M
BLTE vs IBIO Comparison Chart in %
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. IBIO commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a StrongBuy and IBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (BLTE: $63.03 vs. IBIO: $0.82)
Brand notoriety: BLTE and IBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 31% vs. IBIO: 42%
Market capitalization -- BLTE: $2.07B vs. IBIO: $16.07M
BLTE [@Biotechnology] is valued at $2.07B. IBIO’s [@Biotechnology] market capitalization is $16.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileIBIO’s FA Score has 1 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • IBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, IBIO is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 6 TA indicator(s) are bullish while IBIO’s TA Score has 6 bullish TA indicator(s).

  • BLTE’s TA Score: 6 bullish, 5 bearish.
  • IBIO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IBIO is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а -2.13% price change this week, while IBIO (@Biotechnology) price change was +3.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

BLTE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($2.07B) has a higher market cap than IBIO($16.1M). BLTE YTD gains are higher at: -0.111 vs. IBIO (-66.624). IBIO has higher annual earnings (EBITDA): -15.11M vs. BLTE (-50.43M). BLTE has more cash in the bank: 145M vs. IBIO (4.96M). BLTE has less debt than IBIO: BLTE (537K) vs IBIO (3.76M). IBIO has higher revenues than BLTE: IBIO (375K) vs BLTE (0).
BLTEIBIOBLTE / IBIO
Capitalization2.07B16.1M12,851%
EBITDA-50.43M-15.11M334%
Gain YTD-0.111-66.6240%
P/E RatioN/A0.65-
Revenue0375K-
Total Cash145M4.96M2,924%
Total Debt537K3.76M14%
FUNDAMENTALS RATINGS
IBIO: Fundamental Ratings
IBIO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLTEIBIO
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
89%
Momentum
ODDS (%)
Bearish Trend 5 days ago
72%
Bullish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 5 days ago
75%
Bullish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
76%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
57%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLRB4.870.18
+3.84%
Cellectar Biosciences Inc
WULF9.450.01
+0.11%
TeraWulf
DAWN7.51-0.08
-1.05%
Day One Biopharmaceuticals
BBDO2.69-0.03
-1.10%
Banco Bradesco SA
WHG17.76-0.23
-1.28%
Westwood Holdings Group

BLTE and

Correlation & Price change

A.I.dvisor tells us that BLTE and ACOG have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLTE and ACOG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-2.29%
ACOG - BLTE
27%
Poorly correlated
+2.98%
FGHQF - BLTE
25%
Poorly correlated
N/A
URGN - BLTE
23%
Poorly correlated
+1.09%
IBIO - BLTE
23%
Poorly correlated
-0.90%
ELVN - BLTE
23%
Poorly correlated
-0.44%
More

IBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBIO has been loosely correlated with REPL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IBIO jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBIO
1D Price
Change %
IBIO100%
-0.90%
REPL - IBIO
38%
Loosely correlated
+0.37%
LIANY - IBIO
37%
Loosely correlated
+1.41%
NUVB - IBIO
36%
Loosely correlated
+1.71%
LENZ - IBIO
35%
Loosely correlated
+1.13%
STOK - IBIO
31%
Poorly correlated
-0.05%
More